A perianal abscess is a collection of pus in the soft tissue surrounding the anus, most commonly resulting from obstruction and infection of the cryptoglandular anal glands. It is one of the most common surgical emergencies, with an incidence of approximately 20.2 per 100,000, a peak in ages 20–40, and a male predominance. [1-2] The cornerstone of treatment is prompt incision and drainage. [1-2]
1. History
- Pain: Acute onset of perianal pain, often throbbing, worsened by sitting, walking, and defecation [2-3]
- Swelling: Localized perianal swelling, may be progressive over days
- Drainage: Spontaneous purulent or bloody discharge (less common) [1]
- Timing: Duration of symptoms, rapidity of onset, prior episodes
- Triggers: Recent constipation/straining, diarrhea, trauma, anal instrumentation
- Associated symptoms: Fever, malaise, urinary retention (concerning for pelvic sepsis) [3]
- Important negatives: Absence of GI symptoms (diarrhea, bloody stool, weight loss — screen for IBD), no history of recurrent abscesses, no perianal fistula drainage
2. Alarm Features
- Fever, tachycardia, hypotension → systemic sepsis requiring immediate resuscitation and broad-spectrum antibiotics [3]
- Rapidly spreading erythema, crepitus, skin necrosis, pain out of proportion → Fournier's gangrene/necrotizing fasciitis [2][4]
- Urinary retention → deep pelvic sepsis [3]
- Perianal pain without fluctuance → occult deeper abscess (ischiorectal, supralevator, intersphincteric) [3]
- Immunosuppressed patient (neutropenia, HIV, transplant) with perianal pain → may lack classic inflammatory signs; lower threshold for imaging and antibiotics [1]
3. Medications
- Antibiotics are NOT routinely indicated for uncomplicated perianal abscess in healthy patients after adequate I&D [1]
- Indications for antibiotics: surrounding cellulitis, systemic signs of infection (fever, tachycardia, leukocytosis), immunosuppression, diabetes, prosthetic valves/devices [1-2]
- Regimens when indicated:
- Ciprofloxacin 500 mg BID + metronidazole 500 mg TID × 7–10 days (studied for fistula prevention) [5]
- TMP-SMX or clindamycin if MRSA concern [6]
- Broad-spectrum IV antibiotics (piperacillin-tazobactam, carbapenems) for sepsis or Fournier's [7]
- MRSA has been reported in up to 33% of anorectal abscess cultures; targeted therapy recommended if isolated in patients with systemic signs [1]
- Contraindicated: Do not delay drainage in favor of antibiotics alone (except in neutropenic patients with ANC <1000 and no fluctuance) [1]
- Analgesics: NSAIDs, acetaminophen, sitz baths; opioids for severe pain; avoid constipating agents without a stool softener
4. Diet
- High-fiber diet and adequate hydration to prevent constipation and straining, which can worsen perianal pain and impede healing
- Stool softeners (docusate) as adjunct post-drainage
- No specific dietary triggers, but chronic diarrhea (e.g., from IBD) is a risk factor for recurrence
5. Review of Systems
- GI: Diarrhea, bloody stools, abdominal pain, weight loss (screen for Crohn's disease — perianal disease present in 17–43% of CD) [2-3]
- GU: Urinary retention, dysuria (pelvic extension)
- Constitutional: Fevers, chills, rigors, night sweats
- Skin: Other abscesses, hidradenitis suppurativa, pilonidal disease
- Immune: HIV risk factors, chemotherapy, transplant medications
6. Collateral History and Family History
- Family history of IBD — Crohn's disease is a major risk factor; 2.9% of patients presenting with a new anorectal abscess are subsequently diagnosed with Crohn's (median time to diagnosis: 14 months) [8]
- Family history of colorectal cancer (if recurrent or atypical)
- Social context: IV drug use (risk for MRSA, atypical infections), smoking (independent risk factor for fistula formation), sexual practices (STI-related proctitis) [5]
7. Risk Factors
- Male sex (2:1 ratio) [1][9]
- Age 20–40 years [1]
- Crohn's disease (HR 3.51 for fistula formation) [8]
- Diabetes mellitus [2][10]
- Immunosuppression (HIV, chemotherapy, transplant) [1]
- Smoking (increased fistula risk) [5]
- Obesity
- Prior anorectal abscess or surgery [10]
- Malignancy [10]
8. Differential Diagnosis
- Thrombosed external hemorrhoid — acute perianal pain with visible bluish nodule, no fluctuance or erythema
- Anal fissure — sharp pain with defecation, visible tear on anoscopy
- Pilonidal abscess/cyst — located in the natal cleft/sacrococcygeal area, not perianal
- Hidradenitis suppurativa — chronic, recurrent abscesses in apocrine gland-bearing skin (groin, axillae, perineum)
- Anorectal neoplasia — atypical, non-healing perianal mass; biopsy if suspicious [1]
- Sexually transmitted infections (HSV proctitis, syphilitic chancre, LGV) — especially in MSM [1]
- Crohn's perianal disease — multiple fistulae, skin tags, non-healing ulcers [2]
- Fournier's gangrene — cannot miss; rapidly progressive, crepitus, necrosis, systemic toxicity [2][11]
- Bartholin gland abscess (in females) — anterior/lateral vulvar location
9. Past Medical History
- Prior perianal abscess or fistula-in-ano (recurrence up to 44%) [1]
- IBD (especially Crohn's disease)
- Diabetes mellitus (check glucose, HbA1c in all patients per WSES guidelines) [2]
- HIV/AIDS or other immunosuppression
- Prior anorectal surgery or radiation
- Baseline continence status (critical before any sphincter-involving procedure) [1]
10. Physical Exam
- Inspection: Perianal erythema, swelling, visible fluctuant mass, spontaneous drainage, skin tags, fistula openings, scars from prior surgery [1]
- Palpation: Warmth, tenderness, fluctuance; indurated area without fluctuance suggests deeper abscess [3]
- Digital rectal exam (when tolerable): Tender, indurated mass in the intersphincteric groove or above the anorectal ring suggests deep abscess; assess sphincter tone [2]
- Vital signs: Fever (>38°C), tachycardia (>100), hypotension → systemic sepsis [3]
- Concerning findings: Crepitus, skin necrosis, hemorrhagic bullae, pain out of proportion → Fournier's gangrene [2][4]
- Goodsall's rule: Anterior external opening → radial fistula tract; posterior opening → curvilinear tract to posterior midline [1]
11. Lab Studies
- Not routinely needed for simple, superficial perianal abscess in a healthy patient [2]
- When indicated (systemic signs, immunosuppression, diabetes concern):
- CBC with differential (leukocytosis, left shift; leukopenia in immunosuppressed)
- BMP (creatinine, electrolytes)
- Glucose, HbA1c, urine ketones — screen for undiagnosed diabetes (WSES strong recommendation) [2]
- CRP, procalcitonin, lactate — if sepsis suspected [2]
- Blood cultures — if febrile or hemodynamically unstable
- Wound culture: Not routinely useful; consider in recurrent infections, non-healing wounds, immunosuppressed, or suspected MRSA [1]
- LRINEC score if necrotizing fasciitis suspected (WBC, hemoglobin, sodium, glucose, creatinine, CRP) [2][11]
12. Imaging
- Not routinely required for clinically obvious superficial perianal abscess [1]
- Point-of-care ultrasound (POCUS): Useful when diagnosis is uncertain; 94.6% sensitive, 85.4% specific for differentiating abscess from cellulitis; changes management in ~10% of cases. Transperineal POCUS is emerging for perianal/perirectal abscesses [2][12-13]
- CT pelvis with IV contrast: Sensitivity 77%; readily available; best for evaluating extent of deep abscesses, ruling out horseshoe extension, and identifying gas (Fournier's) [2-3]
- MRI pelvis: Gold standard for complex/recurrent abscesses and fistula mapping (sensitivity 87%); limited by availability in the acute setting [1][3]
- Post-drainage: Routine imaging not required; imaging follow-up suggested for recurrence, suspected IBD, or non-healing wound [2]
13. Special Tests
- LRINEC Score: Laboratory Risk Indicator for Necrotizing Fasciitis — score ≥6 raises concern for necrotizing soft tissue infection (PPV 92% in index study, though sensitivity is debated) [2][11]
- Fournier's Gangrene Severity Index (FGSI): For prognosis and risk stratification in suspected Fournier's [2]
- Examination Under Anesthesia (EUA): Gold standard for patients who cannot tolerate bedside exam, or for occult/deep/complex abscesses and fistulae [3]
- Anoscopy/proctoscopy: When tolerated, to evaluate for internal opening, fissure, or proctitis [1]
- Endorectal ultrasound: Sensitivity 87% for abscess detection; operator-dependent; can change surgical management in 10–15% of cases [3]
14. ECG
- Not routinely indicated for perianal abscess
- Obtain ECG if:
- Systemic sepsis with tachycardia or hemodynamic instability (evaluate for sepsis-related arrhythmia or myocardial dysfunction)
- Pre-operative assessment for patients requiring general anesthesia
- Electrolyte abnormalities identified on labs
15. Assessment
- Most perianal abscesses are superficial, uncomplicated, and diagnosed clinically
- Anatomic classification determines management approach: perianal (most common, ~60%), ischiorectal (~30%), intersphincteric, supralevator [1][14]
- 30–50% of patients will ultimately develop a fistula-in-ano after drainage, most within the first year [1][8]
- Atypical presentations: Deep abscess without external findings (intersphincteric, supralevator) — pain referred to perineum, low back, or buttocks; may mimic intra-abdominal pathology [1]
- Complications: Recurrence (up to 44%), fistula-in-ano (15–50%), Fournier's gangrene (rare but life-threatening), fecal incontinence (iatrogenic from sphincter injury) [1]
16. Treatment Plan
Initial stabilization (if septic)
Incision and drainage — the definitive treatment: [1-2]
- Bedside I&D is adequate for most superficial perianal abscesses; outcomes are equivalent to OR drainage [15]
- Incision as close to the anal verge as possible to minimize future fistula tract length [1]
- Break up loculations with blunt dissection
- Do NOT routinely pack — randomized trials show no benefit and increased pain; use simple dressings or a small drain (Pezzer/Malecot catheter) [1][16]
- Local anesthesia: field block with lidocaine ± epinephrine; consider procedural sedation for larger or deeper abscesses
Post-drainage care
- Sitz baths 2–3 times daily
- Analgesics (NSAIDs, acetaminophen ± short-course opioids)
- Stool softeners
- Antibiotics: Reserve for cellulitis, systemic infection, immunosuppression, or diabetes. If prescribed, a 7–10 day course of ciprofloxacin + metronidazole may reduce fistula formation (OR 0.64), though evidence is conflicting [1][5][17]
Special populations
- Neutropenic patients (ANC <1000) without fluctuance: may trial antibiotics alone initially [1]
- Crohn's disease: Drain abscess; avoid aggressive fistulotomy; coordinate with gastroenterology [3]
- Deep/complex abscesses (ischiorectal, supralevator, horseshoe): Require OR drainage, often under general anesthesia; surgical consultation [2-3]
17. Disposition
Discharge criteria (majority of patients)
- Small, superficial perianal abscess in a fit, immunocompetent patient without systemic signs of sepsis [2]
- Adequate drainage achieved at bedside
- Tolerating oral intake and pain controlled
Admission criteria
- Systemic sepsis (fever, tachycardia, hypotension, leukocytosis) [2]
- Deep or complex abscess requiring OR drainage (ischiorectal, supralevator, horseshoe) [2]
- Immunosuppressed or neutropenic patients
- Suspected Fournier's gangrene — emergent surgical consultation [2]
- Failed outpatient management or inability to tolerate bedside I&D
- Significant comorbidities (uncontrolled diabetes, coagulopathy)
Surgical consultation triggers
- Deep or recurrent abscess
- Suspected fistula-in-ano
- Horseshoe abscess
- Crohn's-related perianal disease
- Any concern for necrotizing fasciitis
18. Follow Up / Return Precautions
- Follow-up with surgery or colorectal surgery within 1–2 weeks post-drainage to assess healing and evaluate for fistula formation [1][8]
- 67.5% of fistulae develop within the first year after initial abscess — patients should be counseled about this risk [8]
- Return precautions — instruct patients to return immediately for:
- Worsening pain, swelling, or redness
- Fever or chills
- Persistent or recurrent drainage
- Inability to urinate
- Rapidly spreading redness or skin discoloration (Fournier's concern)
- Expected recovery: Pain should improve significantly within 48–72 hours post-drainage; complete wound healing by secondary intention over 2–6 weeks
- Recurrence: Up to 44% recurrence rate; recurrent abscess warrants evaluation for underlying fistula, IBD, or inadequate initial drainage [1][8]
- Screening for Crohn's disease: Consider in patients with recurrent abscesses, multiple fistulae, or GI symptoms — 2.9% of new abscess patients are subsequently diagnosed with CD [8]
References
1. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula. — Gaertner WB, Burgess PL, Davids JS, et al. Diseases of the Colon and Rectum. 2022.
2. Anorectal Emergencies: WSES-AAST Guidelines. — Tarasconi A, Perrone G, Davies J, et al. World Journal of Emergency Surgery : WJES. 2021.
3. Gastrointestinal Surgical Emergencies Textbook. — Ashley E. Aaron, Andrea Amabile, Ciro Andolfi, et al American College of Surgeons (2021). 2021.
4. Necrotising Soft-Tissue Infections. — Hua C, Urbina T, Bosc R, et al. The Lancet. Infectious Diseases. 2023.
5. Antibiotic Therapy for Prevention of Fistula in-Ano After Incision and Drainage of Simple Perianal Abscess: A Randomized Single Blind Clinical Trial. — Ghahramani L, Minaie MR, Arasteh P, et al. Surgery. 2017.
6. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. — Daum RS, Miller LG, Immergluck L, et al. The New England Journal of Medicine. 2017.
7. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
8. Natural History of Anorectal Sepsis. — Sahnan K, Askari A, Adegbola SO, et al. The British Journal of Surgery. 2017.
9. ACR Appropriateness Criteria® Anorectal Disease. — Expert Panel on Gastrointestinal Imaging, Levy AD, Liu PS, et al. Journal of the American College of Radiology : JACR. 2021.
10. Reviewing Perianal Abscess Management and Recurrence: Lessons From a Trainee Perspective. — Sarofim M, Ooi K. ANZ Journal of Surgery. 2022.
11. Necrotizing Soft Tissue Infections: A Review. — McDermott J, Kao LS, Keeley JA, et al. JAMA Surgery. 2024.
12. Ultrasound Guidelines: Emergency, Point-of-Care, and Clinical Ultrasound Guidelines in Medicine. — American College of Emergency Physicians (2023). 2023.
13. Point-of-Care Ultrasonography for the Diagnosis Of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis. — Gottlieb M, Avila J, Chottiner M, Peksa GD. Annals of Emergency Medicine. 2020.
14. Diagnosis and Treatment of Perianal Crohn Disease: NASPGHAN Clinical Report and Consensus Statement. — de Zoeten EF, Pasternak BA, Mattei P, Kramer RE, Kader HA. Journal of Pediatric Gastroenterology and Nutrition. 2013.
15. "Emergency Room Incision and Drainage of Perirectal Abscess Is Equivalent to Incision and Drainage in the Operating Room". — Maniskas SA, Jebbia MI, Nasir D, et al. The American Surgeon. 2024.
16. Beyond the Knife: A Contemporary Review of Subcutaneous Abscesses. — Mersal M, Embaby O, Ayyad M, et al. ANZ Journal of Surgery. 2025.
17. Antibiotic Use in Prevention of Anal Fistulas Following Incision and Drainage of Anorectal Abscesses: A Systematic Review and Meta-Analysis. — Mocanu V, Dang JT, Ladak F, et al. American Journal of Surgery. 2019.